lr 511 has been researched along with Anochlesia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cascio, G; Fregnan, G; Manghisi, E | 1 |
Fregnan, GB; Vidali, M | 1 |
2 other study(ies) available for lr 511 and Anochlesia
Article | Year |
---|---|
5-Piperazinylalkyl-2(3H)-oxazolones with neuroleptic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Dogs; Indicators and Reagents; Male; Mice; Molecular Structure; Motor Activity; Muscles; Oxazoles; Oxazolone; Piperazines; Rats; Stereotyped Behavior; Structure-Activity Relationship | 1989 |
Pharmacological profile of a new psychotherapeutic agent: 4-p-fluorophenyl-5-N(N'-o-methoxyphenyl)piperazinoethyl-4-oxazolin-2-one (LR 511).
Topics: Aggression; Analgesics; Animals; Anticonvulsants; Antidepressive Agents; Autonomic Nervous System; Behavior, Animal; Catalepsy; Conditioning, Psychological; Dogs; Drug Synergism; Exploratory Behavior; Female; Humans; Hypnotics and Sedatives; Lethal Dose 50; Male; Mice; Motor Activity; Muscle Contraction; Oxazoles; Piperazines; Psychotropic Drugs; Rabbits; Rats; Tranquilizing Agents | 1977 |